指南与共识儿科与产科急症重症综合管理与镇静镇痛

COVID-19 大流行期间外科手术的国际指南与推荐:一项系统综述

International guidelines and recommendations for surgery during Covid-19 pandemic: A Systematic Review.
指南 / 共识 · Int J Surg · 2020-05-23
一句话结论系统综述汇总22篇外科学会与卫生机构文件:应按分诊优先排序、虚拟肿瘤委员会讨论、个体化腹腔镜决策,并规范围术期人员管理。

该研究按 AMSTAR 与 2009 PRISMA 指南系统检索英文文献,最终分析 22 篇论文与声明,评估 COVID-19 大流行期间普外科管理相关推荐。结果显示,外科学会已建立分诊与优先排序标准以区分可推迟与不可推迟的手术;肿瘤病例优先排序需权衡延迟诊疗与 COVID-19 暴露风险,指南广泛同意经虚拟肿瘤委员会讨论并考虑替代治疗;腹腔镜手术建议个体化评估,前提是具备适当个人防护设备;围术期与术中人员管理及 COVID-19 病例诱导、操作和复苏手法也有相当共识。结论强调应高效应对紧急情况、从非必需环节调配资源,同时保障高优先级非 COVID-19 疾病救治。

要点

  • 外科学会已建立分诊与优先排序标准,用于识别可推迟至大流行之后的手术与不应推迟的手术。
  • 肿瘤病例优先排序困难,需权衡癌症诊断或治疗延迟与 COVID-19 暴露风险。
  • 指南广泛同意手术指征应经虚拟肿瘤委员会讨论,并考虑替代治疗方案。
  • 腹腔镜手术建议个体化评估,前提是具备适当个人防护设备以降低传播风险。
  • 围术期与术中人员管理、COVID-19 病例诱导、操作与复苏手法的技术建议已有相当共识。

适用人群与场景

  • 普外科患者,包括需急诊手术者与不可推迟的肿瘤病例。
  • COVID-19 病例的围术期与术中管理。

诊断标准与关键阈值

  • 外科学会已建立分诊与优先排序标准,用于区分可推迟至大流行之后的手术与不应推迟的手术。

处置流程与药物剂量

  • 手术指征应经虚拟肿瘤委员会讨论,并考虑替代治疗方案。
  • 腹腔镜手术采用个体化评估,前提是具备适当个人防护设备以降低传播风险。
  • 围术期与术中人员管理及 COVID-19 病例的诱导、操作与复苏手法遵循已发表的技术建议。

研究设计与关键结果

  • 系统综述按 AMSTAR 与 2009 PRISMA 指南检索英文文献,最终分析 22 篇论文与声明。
  • 外科学会已建立分诊与优先排序标准以区分可推迟与不可推迟的手术。
  • 肿瘤病例优先排序需权衡癌症诊断或治疗延迟与 COVID-19 暴露风险,指南广泛同意经虚拟肿瘤委员会讨论并考虑替代治疗。
  • 腹腔镜手术建议个体化评估,前提是具备适当个人防护设备以降低传播风险。
  • 围术期与术中人员管理及 COVID-19 病例诱导、操作与复苏手法有相当共识。

证据类型、等级与局限

  • 证据类型:系统综述,按 AMSTAR 与 2009 PRISMA 指南进行。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 可依据外科学会分诊与优先排序标准区分可推迟与不应推迟的手术。
  • 肿瘤病例手术指征应经虚拟肿瘤委员会讨论并考虑替代治疗方案。
  • 腹腔镜手术需个体化评估,并确保具备适当个人防护设备。
  • 需重视围术期与术中人员管理及 COVID-19 病例诱导、操作与复苏手法的技术建议。

指南或共识出处

  • International guidelines and recommendations for surgery during Covid-19 pandemic: A Systematic Review(International Journal of Surgery)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: During the COVID-19 pandemic, surgical departments were forced to re-schedule their activity giving priority to urgent procedures and non-deferrable oncological cases. There is a lack of evidence-based literature providing clinical and organizational guidelines for the management of a general surgery department. Aim of our study was to review the available recommendations published by general Surgery Societies and Health Institutions and evaluate the underlying Literature.

MATERIALS AND METHODS: A review of the English Literature was conducted according to the AMSTAR and to the 2009 Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.

RESULTS: After eligibility assessment, a total of 22 papers and statements were analyzed. Surgical societies have established criteria for triage and prioritization in order to identify procedures that can be postponed after the pandemic and those that should not. Prioritization among oncologic cases represents a difficult task: clinicians have to balance a possible delay in cancer diagnosis or treatment against the risk for a potential COVID-19 exposure. There is broad agreement among guidelines that indication to proceed with surgery should be discussed in virtual Tumor Boards taking into consideration alternative therapeutic approaches. Several guidelines deal with the role of laparoscopic surgery during the pandemic: a tailored approach is currently suggested, with a case-by-case evaluation provided that appropriate personal protective equipment is available in order to minimize the potential risk of transmission. Finally, there is a considerable agreement in the published Literature concerning the management of the personnel during the peri- and intraoperative phase and on the technical advices regarding the induction, operative and recover maneuvers in COVID-19 cases.

CONCLUSIONS: During COVID-19 pandemic, it is of paramount importance to face the emergency in the most effective and efficient manner, retrieving resources from non-essential settings and, at the same time, providing care to high priority non-COVID-19 related diseases.

来源:Int J Surg,查看原文。版权归原作者所有。

参考来源

  1. Moletta L, Pierobon ES, Capovilla G, et al. International guidelines and recommendations for surgery during Covid-19 pandemic: A Systematic Review. Int J Surg. 2020. PMID: 32454253. doi:10.1016/j.ijsu.2020.05.061

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。